[[Bernard Belleau]]

CATEGORIES: 1925 births, 1989 deaths, Canadian Medical Hall of Fame, Canadian pharmacologists, Fellows of the Royal Society of Canada, Officers of the Order of Canada, People from Montreal, Université de Montréal alumni, McGill University alumni

Bernard Belleau, [tpl]Post-nominals|country=CAN|OC|FRSC[/tpl] (March 15, 1925 – September 4, 1989) was a Canadian molecular pharmacologist best known for his role in the discovery of Lamivudine, a drug used in the treatment of HIV and Hepatitis B infection. 
Born in Montreal, Quebec, he gained his B.Sc. (1947) and M.Sc. (1948) from the Université de Montréal and his PhD in 1950 at McGill University. During his time at the Sloan-Kettering Institute for Cancer Research he discovered the Fujimoto-Belleau reaction, which is named after him and George I. Fujimoto.[ref]
